229 related articles for article (PubMed ID: 30592984)
1. Understanding relaxin signalling at the cellular level.
Valkovic AL; Bathgate RA; Samuel CS; Kocan M
Mol Cell Endocrinol; 2019 May; 487():24-33. PubMed ID: 30592984
[TBL] [Abstract][Full Text] [Related]
2. Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.
Chow BS; Chew EG; Zhao C; Bathgate RA; Hewitson TD; Samuel CS
PLoS One; 2012; 7(8):e42714. PubMed ID: 22936987
[TBL] [Abstract][Full Text] [Related]
3. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
[TBL] [Abstract][Full Text] [Related]
4. The anti-fibrotic actions of relaxin are mediated through AT
Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
[TBL] [Abstract][Full Text] [Related]
5. Emerging roles for the relaxin/RXFP1 system in cancer therapy.
Thanasupawat T; Glogowska A; Nivedita-Krishnan S; Wilson B; Klonisch T; Hombach-Klonisch S
Mol Cell Endocrinol; 2019 May; 487():85-93. PubMed ID: 30763603
[TBL] [Abstract][Full Text] [Related]
6. The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2.
Scott DJ; Rosengren KJ; Bathgate RA
Mol Endocrinol; 2012 Nov; 26(11):1896-906. PubMed ID: 22973049
[TBL] [Abstract][Full Text] [Related]
7. Sub-picomolar relaxin signalling by a pre-assembled RXFP1, AKAP79, AC2, beta-arrestin 2, PDE4D3 complex.
Halls ML; Cooper DM
EMBO J; 2010 Aug; 29(16):2772-87. PubMed ID: 20664520
[TBL] [Abstract][Full Text] [Related]
8. The relaxin receptor as a therapeutic target - perspectives from evolution and drug targeting.
Bathgate RAD; Kocan M; Scott DJ; Hossain MA; Good SV; Yegorov S; Bogerd J; Gooley PR
Pharmacol Ther; 2018 Jul; 187():114-132. PubMed ID: 29458108
[TBL] [Abstract][Full Text] [Related]
9. Relaxin signaling activates peroxisome proliferator-activated receptor gamma.
Singh S; Bennett RG
Mol Cell Endocrinol; 2010 Feb; 315(1-2):239-45. PubMed ID: 19712722
[TBL] [Abstract][Full Text] [Related]
10. The relaxin family peptide receptor 1 (RXFP1): An emerging player in human health and disease.
Chen TY; Li X; Hung CH; Bahudhanapati H; Tan J; Kass DJ; Zhang Y
Mol Genet Genomic Med; 2020 Apr; 8(4):e1194. PubMed ID: 32100955
[TBL] [Abstract][Full Text] [Related]
11. A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1.
Hossain MA; Kocan M; Yao ST; Royce SG; Nair VB; Siwek C; Patil NA; Harrison IP; Rosengren KJ; Selemidis S; Summers RJ; Wade JD; Bathgate RAD; Samuel CS
Chem Sci; 2016 Jun; 7(6):3805-3819. PubMed ID: 30155023
[TBL] [Abstract][Full Text] [Related]
12. Real-time examination of cAMP activity at relaxin family peptide receptors using a BRET-based biosensor.
Valkovic AL; Leckey MB; Whitehead AR; Hossain MA; Inoue A; Kocan M; Bathgate RAD
Pharmacol Res Perspect; 2018 Oct; 6(5):e00432. PubMed ID: 30263124
[TBL] [Abstract][Full Text] [Related]
13. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.
Klonisch T; Glogowska A; Thanasupawat T; Burg M; Krcek J; Pitz M; Jaggupilli A; Chelikani P; Wong GW; Hombach-Klonisch S
Br J Pharmacol; 2017 May; 174(10):1025-1033. PubMed ID: 27443788
[TBL] [Abstract][Full Text] [Related]
14. ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.
Kocan M; Sarwar M; Ang SY; Xiao J; Marugan JJ; Hossain MA; Wang C; Hutchinson DS; Samuel CS; Agoulnik AI; Bathgate RAD; Summers RJ
Sci Rep; 2017 Jun; 7(1):2968. PubMed ID: 28592882
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective actions of relaxin.
Martin B; Romero G; Salama G
Mol Cell Endocrinol; 2019 May; 487():45-53. PubMed ID: 30625345
[TBL] [Abstract][Full Text] [Related]
16. International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.
Halls ML; Bathgate RA; Sutton SW; Dschietzig TB; Summers RJ
Pharmacol Rev; 2015; 67(2):389-440. PubMed ID: 25761609
[TBL] [Abstract][Full Text] [Related]
17. Roles of the receptor, the ligand, and the cell in the signal transduction pathways utilized by the relaxin family peptide receptors 1-3.
Summers RJ; Bathgate RA; Wade JD; van der Westhuizen ET; Halls ML
Ann N Y Acad Sci; 2009 Apr; 1160():99-104. PubMed ID: 19416167
[TBL] [Abstract][Full Text] [Related]
18. Relaxin family peptides and their receptors.
Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ
Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914
[TBL] [Abstract][Full Text] [Related]
19. Receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Ann N Y Acad Sci; 2005 May; 1041():61-76. PubMed ID: 15956688
[TBL] [Abstract][Full Text] [Related]
20. Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis.
Chow BS; Kocan M; Bosnyak S; Sarwar M; Wigg B; Jones ES; Widdop RE; Summers RJ; Bathgate RA; Hewitson TD; Samuel CS
Kidney Int; 2014 Jul; 86(1):75-85. PubMed ID: 24429402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]